Search by Drug Name or NDC

    NDC 00169-2200-11 NovoLog Mix 70/30 100 [iU]/mL Details

    NovoLog Mix 70/30 100 [iU]/mL

    NovoLog Mix 70/30 is a SUBCUTANEOUS INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novo Nordisk. The primary component is INSULIN ASPART.

    Product Information

    NDC 00169-2200
    Product ID 0169-2200_ecfd53fb-5887-48df-bc66-c32f8ff0cf67
    Associated GPIs 27104070001820
    GCN Sequence Number 051718
    GCN Sequence Number Description insulin aspart prot/insuln asp VIAL 70-30/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 19057
    HICL Sequence Number 023400
    HICL Sequence Number Description INSULIN ASPART PROTAMINE HUMAN/INSULIN ASPART
    Brand/Generic Brand
    Proprietary Name NovoLog Mix 70/30
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin aspart
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units [iU]/mL
    Substance Name INSULIN ASPART
    Labeler Name Novo Nordisk
    Pharmaceutical Class Insulin Analog [EPC], Insulin [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA021172
    Listing Certified Through 2024-12-31

    Package

    NDC 00169-2200-11 (00169220011)

    NDC Package Code 0169-2200-11
    Billing NDC 00169220011
    Package 1 VIAL, GLASS in 1 CARTON (0169-2200-11) / 10 mL in 1 VIAL, GLASS
    Marketing Start Date 2021-07-01
    NDC Exclude Flag N
    Pricing Information N/A